Gene therapy by proteasome activator PA28γ, improves motor coordination and proteasome function in Huntington;s disease YAC128 mice.
Jeon, J., Kim, W., et. al.
Neuroscience., 2016
2
Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington’s disease.
Seo, H., Hong, C., et. al.
Brain., 2015
3
Neuroanatomical Visualization of the impaired Striatal Connectivity in Huntington’s Disease Mouse Model.
Kim, D., Jeon, J., et. al.
Mol Neurobiol., 2015
4
Prediction of miRNA-mRNA associations in Alzheimer’s disease mice using network topology.
Noh, H., et. al.
BMC Genomics., 2014
5
Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation.
Noh, H., Seo, H.
Neuroscience., 2014
6
Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model mice.
Kim, W., Seo, H.
Biochem Biophys Res Commun., 2013
7
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease.
Cooper, O., Seo, H., et al.
Sci Transl Med., 2012
8
The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer’s disease and Down’s syndrome.
Seo, H., Isacson, O.
J Neurochem., 2010
9
Compensatory changes in the ubiquitin-proteasome system, BDNF and mitochondrial complex Ⅱ/Ⅲ in YAC72 and R6/2 transgenic mice partially model Huntington’s disease (HD) patients.
Seo, H., et. al.
Hum Mol Genet., 2008
10
Proteasome activator enhances survival of Huntington’s disease neuronal model cells.